Skip to main content
. 2014 Jun 12;15:222. doi: 10.1186/1745-6215-15-222

Table 3.

Feasibility outcomes and estimated sample sizes

Outcome Demonstration of feasibility Estimated actual proportion Desired precision Required sample size
Administration of first dose of albumin within two hours of furosemide administration
Lower-bound of 95% confidence interval greater than 85%
0.925
0.075
47
Administration of at full 72 hours of study treatment
Lower-bound of 95% confidence interval greater than 80%
0.9
0.1
34
Absence of hyperoncotic albumin in control arm
Lower-bound of 95% confidence interval greater than 85%
0.95
0.1
18
Randomization rate of patients eligible by screening criteria Lower-bound of 95% confidence interval greater than 50% 0.65 0.15 39